{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T22:20:27Z","timestamp":1759702827204},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1038\/sj.eye.6700495","type":"journal-article","created":{"date-parts":[[2003,8,20]],"date-time":"2003-08-20T09:56:08Z","timestamp":1061373368000},"page":"731-734","source":"Crossref","is-referenced-by-count":13,"title":["Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion"],"prefix":"10.1038","volume":"17","author":[{"given":"M","family":"Weger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Stanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Temmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Fellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Schmut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,8,20]]},"reference":[{"key":"BF6700495_CR1","first-page":"109","volume-title":"Diseases of the Retina and Vitreous","author":"JB Blice","year":"1999","unstructured":"Blice JB, Brown GC . Retinal vascular occlusive disease. In: Spaide RF (ed). Diseases of the Retina and Vitreous. WB Saunders: Philadelphia, 1999, pp 109\u2013127."},{"key":"BF6700495_CR2","first-page":"271","volume-title":"Retina \u2013 Vitreous \u2013 Macula","author":"GC Brown","year":"1999","unstructured":"Brown GC . Retinal artery occlusive diseases. In: Guyer DR, Yanuzzi LA, Chang S, Shields YA, Green WR (eds). Retina \u2013 Vitreous \u2013 Macula. WB Saunders: Philadelphia, 1999, pp 271\u2013285."},{"key":"BF6700495_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/bjo.84.2.154","volume":"84","author":"M Cahill","year":"2000","unstructured":"Cahill M, Karabatzaki M, Meleady R, Refsum H, Ueland P, Shields D et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol 2000; 84: 154\u2013157.","journal-title":"Br J Ophthalmol"},{"key":"BF6700495_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0002-9394(02)01471-X","volume":"134","author":"M Weger","year":"2002","unstructured":"Weger M, Stanger O, Deutschmann H, Leitner FJ, Renner W, Schmut O et al. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol 2002; 134: 57\u201361.","journal-title":"Am J Ophthalmol"},{"key":"BF6700495_CR5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V95.5.1517.005k48_1517_1532","volume":"95","author":"DA Lane","year":"2000","unstructured":"Lane DA, Grant PJ . Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95: 1517\u20131532.","journal-title":"Blood"},{"key":"BF6700495_CR6","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1056\/NEJM200104193441607","volume":"344","author":"U Seligsohn","year":"2001","unstructured":"Seligsohn U, Lubetsky A . Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222\u20131231.","journal-title":"N Engl J Med"},{"key":"BF6700495_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64\u201367.","journal-title":"Nature"},{"key":"BF6700495_CR8","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"SR Poort","year":"1996","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM . A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698\u20133703.","journal-title":"Blood"},{"key":"BF6700495_CR9","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V89.8.2817","volume":"89","author":"FR Rosendaal","year":"1997","unstructured":"Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth Jr WT et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89: 2817\u20132821.","journal-title":"Blood"},{"key":"BF6700495_CR10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.V90.5.1747","volume":"90","author":"FR Rosendaal","year":"1997","unstructured":"Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL . A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 90: 1747\u20131750.","journal-title":"Blood"},{"key":"BF6700495_CR11","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1161\/01.CIR.97.11.1037","volume":"97","author":"CJ Doggen","year":"1998","unstructured":"Doggen CJ, Cats VM, Bertina RM, Rosendaal FR . Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998; 97: 1037\u20131041.","journal-title":"Circulation"},{"key":"BF6700495_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1056\/NEJM199504063321403","volume":"332","author":"PM Ridker","year":"1995","unstructured":"Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP . Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912\u2013917.","journal-title":"N Engl J Med"},{"key":"BF6700495_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(95)90310-0","volume":"345","author":"J Emmerich","year":"1995","unstructured":"Emmerich J, Poirier O, Evans A, Marques-Vidal P, Arveiler D, Luc G et al. Myocardial infarction, Arg506 to Gln factor V mutation, and activated protein C resistance. Lancet 1995; 345: 321.","journal-title":"Lancet"},{"key":"BF6700495_CR14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1055\/s-0038-1653820","volume":"73","author":"K Kontula","year":"1995","unstructured":"Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Makelin R, Hamalainen L et al. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995; 73: 558\u2013560.","journal-title":"Thromb Haemost"},{"key":"BF6700495_CR15","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1182\/blood.V91.10.3562","volume":"91","author":"V De Stefano","year":"1998","unstructured":"De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischaemic disease in young patients. Blood 1998; 91: 3562\u20133565.","journal-title":"Blood"},{"key":"BF6700495_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/01.CIR.99.8.999","volume":"99","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, Hennekens CH, Miletich JP . G20210A mutation in prothrombin gene and risk of myocardial infarction stroke, and venous thrombosis in a large cohort of US men. Circulation 1999; 99: 999\u20131004.","journal-title":"Circulation"},{"key":"BF6700495_CR17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0002-9394(00)00461-X","volume":"129","author":"J Larsson","year":"2000","unstructured":"Larsson J . Central retinal artery occlusion in a patient homozygous for factor V Leiden. Am J Ophthalmol 2000; 129: 816\u2013817.","journal-title":"Am J Ophthalmol"},{"key":"BF6700495_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0002-9394(14)70910-9","volume":"124","author":"T Talmon","year":"1997","unstructured":"Talmon T, Scharf J, Mayer E, Lanir N, Miller B, Brenner B . Retinal artery occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofoalte reductase mutations. Am J Ophthalmol 1997; 124: 689\u2013691.","journal-title":"Am J Ophthalmol"},{"key":"BF6700495_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00006982-199808000-00015","volume":"18","author":"R Tayyanipour","year":"1998","unstructured":"Tayyanipour R, Pulido JS, Postel EA, Lipkowitz JL, Pisciotta A, Braza E . Arterial vascular occlusion associated with factor V Leiden gene mutation. Retina 1998; 18: 376\u2013377.","journal-title":"Retina"},{"key":"BF6700495_CR20","first-page":"971","volume":"117","author":"S Dhar-Munshi","year":"1999","unstructured":"Dhar-Munshi S, Ayliffe WH, Jayne D . Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor. Arch Ophthalmol 1999; 117: 971\u2013973.","journal-title":"Arch Ophthalmol"},{"key":"BF6700495_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/A:1010639332737","volume":"23","author":"K Greiner","year":"1999","unstructured":"Greiner K, Peetz D, Winkgen A, Prellwitz W, Pfeiffer N, Hafner G . Genetic thrombophilia in patients with retinal vascular occlusion. Int Opthalmol 1999; 23: 155\u2013160.","journal-title":"Int Opthalmol"},{"key":"BF6700495_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/eye.2001.164","volume":"15","author":"O Salomon","year":"2001","unstructured":"Salomon O, Huna-Baron R, Moisseiev J, Rosenberg N, Rubovitz A, Steinberg DM et al. Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source. Eye 2001; 15: 511\u2013514.","journal-title":"Eye"},{"key":"BF6700495_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/bjo.85.7.883","volume":"85","author":"M Chak","year":"2001","unstructured":"Chak M, Wallace GR, Graham EM, Stanford MR . Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease. Br J Ophthalmol 2001; 85: 883\u2013886.","journal-title":"Br J Ophthalmol"},{"key":"BF6700495_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1055\/s-0038-1657574","volume":"78","author":"B Dahlb\u00e4ck","year":"1997","unstructured":"Dahlb\u00e4ck B . Resistance to activated protein C caused by factor VR506Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 1997; 78: 483\u2013488.","journal-title":"Thromb Haemost"},{"key":"BF6700495_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s004170050265","volume":"237","author":"A Sagripanti","year":"1999","unstructured":"Sagripanti A, Romani A, Ferretti A, Ragone MC, Baicchi U, Carpi A et al. Blood coagulation parameters in retinal arterial occlusion. Graefes Arch Clin Exp Ophthalmol 1999; 237: 480\u2013483.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BF6700495_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00055735-199702000-00010","volume":"8","author":"JJ Harding","year":"1997","unstructured":"Harding JJ . Recent studies of risk factors and protective factors for cataract. Curr Opin Ophthalmol 1997; 8: 46\u201349.","journal-title":"Curr Opin Ophthalmol"},{"key":"BF6700495_CR27","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/bjo.79.11.1036","volume":"79","author":"CA Donnelly","year":"1995","unstructured":"Donnelly CA, Seth J, Clayton RM, Phillips CI, Cuthbert J, Prescott RJ . Some blood plasma constituents correlate with human cataract. Br J Ophthalmol 1995; 79: 1036\u20131041.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6700495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6700495","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6700495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:13:04Z","timestamp":1684411984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6700495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF6700495"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6700495","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}